Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |